(Q33343355)

26 July 2017

Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study (English)

1 reference

26 July 2017

1 reference

Hannes Steiner

1

1 reference

26 July 2017

Lorenz Höltl

2

1 reference

26 July 2017

Walter Wirtenberger

3

1 reference

26 July 2017

Andreas P Berger

4

1 reference

26 July 2017

Georg Bartsch

5

1 reference

26 July 2017

Alfred Hobisch

6

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

26 July 2017

1 reference

26 July 2017

60

1 reference

26 July 2017

324-328

1 reference

26 July 2017

2

1 reference

Treatment in germ cell tumours: state of the art.

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Radiotherapy for stages I and IIA/B testicular seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Postoperative radiotherapy for Stage I/II seminoma: results for 212 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

The effect of radiotherapy treatment changes on sites of relapse in stage I testicular seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Long-term side effects of treatment for testis cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Second malignancies following pure seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Surveillance for stage I testicular seminoma. a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Cisplatin neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Long-term toxicity of chemotherapy for testicular cancer--the cost of cure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Simple nontoxic treatment of advanced metastatic seminoma with carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Adjuvant chemotherapy in stage I and stage II testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Orchidectomy alone for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Surveillance following orchidectomy for stage I testicular seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Surveillance following orchidectomy for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Prognostic Factors for Relapse in Stage I Testicular Seminoma Treated With Surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Late recurrence of seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Cost-effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Limitations to the use of surveillance as an option in the management of stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

A study of post-orchiectomy surveillance in stage I testicular seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901708-9

7 January 2021

10.1016/S0090-4295(02)01708-9

Identifiers

DOI

1 reference

26 July 2017

1 reference